McQuilten ZK, Busija L, Seymour JF, Stanworth S, et al. Hemoglobin is a key determinant of quality of life before and during azacitidine-based therapy for myelodysplasia and low blast count acute myeloid leukemia. Leuk Lymphoma 2021 Dec 17:1-8. doi: 10.1080/10428194.2021.2012664.
PMID: 34915809